Computershare Limited, the world's largest stock transfer agent, has upgraded its U.S. trading status from the Pink Limited Market to the OTCQX Best Market. This move simplifies its trading structure in the U.S. and provides investors with better access to real-time financial disclosures and share ownership information. Computershare serves over 25,000 clients globally and supports various corporate services, reinforcing its commitment to transparency and governance. The upgrade reflects the company's adherence to high financial and regulatory standards, benefiting U.S. investors and brokers.
Computershare Limited's upgrade to the OTCQX Best Market comes as a backdrop to a Financials sector where 68 of 118 US stocks rose and 24 fell on Pluang. For readers following Financials, here is Pluang's market snapshot as of Oct 12, 2026 17:02 WIB: Valley National Bancorp Common Stock (VLY) was priced at USD 12.93 with a 1-day change of +2.46% and a typical hold time of 3 days, SoFi Technologies Inc (SOFI) at USD 15.43 with a -2.34% change and a 61-day hold time, and Lufax Holding Ltd (LU) at USD 1.00 with a +2.00% change and a 14-day hold time.
Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...
Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...
The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...
Fate Therapeutics has appointed Jamie Harrell as Senior Vice President of Market Development & Commercial Operations to spearhead the commercialization of its CAR T-cell therapies, including FT819 and FT839, targeting autoimmune diseases like lupus n...
Iridex Corporation announced a two-year clinical study demonstrating that MicroPulse transscleral laser therapy significantly reduces intraocular pressure (IOP) and medication use in patients with early to advanced glaucoma. The study, involving 84 e...
